Growth
High Revenue Growth
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Consistently high revenue growth: in each of the last 6 quarters, revenue was at least 20% above the same quarter a year earlier (year-over-year). This filters out stocks that only grew strongly in a single quarter — the goal is steady, fast growth sustained over a year and a half. Requirement: at least 6 quarters of data history.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(16)
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
- YoY (Year-over-Year)
- Year over Year: the quarter is compared with the same quarter of the prior year, not the previous quarter. This removes seasonal effects (holiday shopping, etc.) and is the standard for growth rates.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AAOI Applied Optoelectronics, Inc. | 08/06 | +1,099 % | 92 10/25 | Stage 2 | B 62 | 4 of 9 | 7.6 $ | Communication Equipment | Sells AI | — | — | Technology | 94.30 $ | +322.9 % | +266.1 % | +312.4 % | −40.7 % | +59.4 % | 98 | 42 | 12.0 % | 12.7 % | 3.69 | — | 84.0 | 14.9 | 6.9 | — | 0.78 | 38.4 | -8.6 % | 29.6 % | -8.6 % | -6.1 % | -3.3 % | 0.16 | 70.6 % | +82.8 % | — | 0.0 % | 0.0 % | 7.6 | 68.3 % | 12.9 % | 4.2 (5) |
| CRDO Credo Technology Group Holding Ltd | 09/02 | +487 % | 72 7/25 | Stage 2 | A 87 | 7 of 9 | 38.5 $ | Semiconductors | Sells AI | — | Technology | 207.00 $ | +89.0 % | +63.6 % | +85.6 % | −13.2 % | +34.9 % | 96 | 93 | 10.5 % | 11.3 % | 3.20 | 83.7 | 35.1 | 28.8 | 18.8 | 94.6 | — | 77.5 | 35.7 % | 68.0 % | 35.4 % | 34.4 % | 17.9 % | 0.01 | 89.9 % | +205.7 % | — | 0.0 % | 0.0 % | 19.7 | 75.9 % | 3.6 % | 4.6 (13) | |
| TVTX Travere Therapeutics Inc | 08/05 | +82 % | 68 6/22 | Stage 2 | B 64 | 5 of 9 | 5.1 $ | Biotechnology | Uses AI | — | Healthcare | 55.90 $ | +46.4 % | +44.7 % | +261.8 % | −1.8 % | +5.8 % | 96 | 42 | 3.6 % | 4.6 % | 1.11 | — | 76.3 | 9.5 | 51.5 | 292.4 | — | 136.5 | -29.0 % | 56.0 % | -4.0 % | -69.4 % | -6.5 % | 3.35 | 17.8 % | +110.5 % | — | 0.0 % | 0.0 % | -2.7 | 113.4 % | 16.9 % | 4.6 (15) | |
| ELA Envela Corp | 08/05 | +95 % | 94 13/31 | Stage 2 | A 79 | 8 of 9 | 0.6 $ | Luxury Goods | Neutral | — | Consumer Cyclical | 21.70 $ | +100.4 % | +120.5 % | +300.0 % | −9.2 % | +17.5 % | 96 | 92 | 6.6 % | 6.7 % | 0.37 | 27.2 | 54.1 | 1.9 | 7.4 | 26.7 | — | 18.7 | — | 21.5 % | 7.2 % | 32.0 % | 17.5 % | 0.26 | — | +33.6 % | — | 0.0 % | 0.0 % | 11.9 | 19.6 % | 4.9 % | 5.0 (2) | |
| MTSI MACOM Technology Solutions Holdings, Inc. | 08/06 | +176 % | 95 11/25 | Stage 2 | B 68 | 8 of 9 | 20.4 $ | Semiconductors | Sells AI | — | — | Technology | 251.40 $ | +117.3 % | +111.9 % | +83.4 % | −6.9 % | +59.5 % | 95 | 75 | 6.2 % | 6.4 % | 1.66 | 100.8 | 36.8 | 19.0 | 12.8 | 133.8 | 2.05 | 68.4 | 17.6 % | 55.7 % | 16.5 % | 13.5 % | 5.5 % | 0.35 | 70.4 % | +32.6 % | — | 0.0 % | 0.0 % | 9.4 | 99.6 % | 3.0 % | 4.3 (16) |
| SITM Sitime Corporation | 08/05 | +172 % | 72 7/25 | Stage 2 | A 77 | 7 of 9 | 15.1 $ | Semiconductors | Sells AI | — | — | Technology | 535.20 $ | +100.1 % | +87.9 % | +163.8 % | −25.1 % | +56.5 % | 95 | 12 | 8.0 % | 7.5 % | 2.91 | — | 71.9 | 39.6 | 12.1 | 278.7 | 3.82 | 3,076.2 | -4.2 % | 55.7 % | -6.4 % | -2.6 % | -2.3 % | 0.00 | 89.6 % | +61.2 % | — | 0.0 % | 0.0 % | 16.1 | 89.0 % | 5.0 % | 3.9 (7) |
| IBRX Immunitybio Inc | 08/04 | +57 % | 56 5/22 | Stage 2 | C 51 | 3 of 9 | 7.4 $ | Biotechnology | Uses AI | — | Healthcare | 7.20 $ | +269.7 % | +309.8 % | +191.5 % | −37.3 % | +77.1 % | 94 | 42 | 7.8 % | 7.0 % | 0.08 | — | 0.0 | 52.7 | — | — | — | -9.0 | -157.9 % | 99.3 % | 0.0 % | 0.0 % | -34.4 % | — | -134.5 % | +668.3 % | — | 0.0 % | 0.0 % | -23.1 | 17.6 % | 34.6 % | 4.6 (5) | |
| RKLB Rocket Lab USA Inc. | 08/06 | +539 % | 66 8/29 | Stage 2 | B 63 | 4 of 9 | 41.7 $ | Aerospace & Defense | – | — | — | Industrials | 65.00 $ | +36.4 % | +27.0 % | +41.4 % | −46.6 % | +76.1 % | 93 | 42 | 8.8 % | 9.5 % | 2.55 | — | 0.0 | 61.4 | 19.0 | — | — | -16.4 | -22.4 % | 36.6 % | -26.9 % | -13.6 % | -6.6 % | 0.07 | 80.3 % | +38.0 % | — | 0.0 % | 0.0 % | 9.1 | 59.0 % | 8.0 % | 4.1 (15) |
| OUST Ouster, Inc. Common Stock | 08/06 | +244 % | 61 6/25 | Stage 2 | B 58 | 6 of 9 | 2.6 $ | Electronic Components | Sells AI | — | Technology | 39.00 $ | +108.7 % | +141.8 % | +66.9 % | −18.8 % | +33.7 % | 93 | 42 | 15.3 % | 13.5 % | 3.18 | — | 0.0 | 14.2 | — | — | — | -0.8 | -39.6 % | 47.7 % | -30.1 % | -25.2 % | -14.7 % | — | 72.2 % | +52.5 % | — | 0.0 % | 0.0 % | -0.7 | 50.0 % | 9.3 % | 4.3 (6) | |
| SEI Solaris Energy Infrastructure, Inc | 07/22 | +327 % | 79 3/10 | Stage 2 | B 73 | 5 of 9 | 5.1 $ | Oil & Gas Equipment & Services | Sells AI | — | Energy | 51.40 $ | +70.3 % | +76.6 % | +59.0 % | −7.8 % | +83.5 % | 92 | 87 | 7.0 % | 7.1 % | 1.18 | — | 384.6 | 7.3 | — | — | 0.94 | 20.2 | 25.8 % | 46.9 % | 6.7 % | 8.7 % | 5.0 % | — | 26.1 % | +98.7 % | — | 0.9 % | 66.7 % | 4.1 | 113.1 % | 26.1 % | 4.9 (8) | |
| GH Guardant Health Inc | 07/29 | +89 % | 78 7/22 | Stage 2 | B 55 | 6 of 9 | 21.5 $ | Diagnostics & Research | Sells AI | — | Healthcare | 162.00 $ | +28.1 % | +50.2 % | +295.3 % | −2.0 % | +15.7 % | 92 | 42 | 5.3 % | 5.7 % | 1.59 | — | 0.0 | 18.2 | 63.1 | — | — | -5.4 | -40.2 % | 65.0 % | -38.3 % | -4,584.5 % | -18.1 % | -6.60 | -9.5 % | +32.9 % | — | 0.0 % | 0.0 % | 0.1 | 106.0 % | 9.0 % | 4.7 (23) | |
| AXSM Axsome Therapeutics Inc | 08/03 | +58 % | 78 7/22 | Stage 2 | B 55 | 5 of 9 | 11.6 $ | Biotechnology | – | — | — | Healthcare | 218.00 $ | +32.5 % | +56.9 % | +115.0 % | −8.8 % | +29.5 % | 92 | 42 | 3.6 % | 3.5 % | 0.60 | — | 333.3 | 16.3 | 205.5 | — | — | -14.8 | -32.8 % | 92.6 % | -26.6 % | -349.4 % | -16.8 % | 4.03 | 7.6 % | +65.6 % | — | 0.0 % | 0.0 % | -3.1 | 76.6 % | 9.2 % | 4.7 (19) |
| ETON Eton Pharmaceuticals Inc | 08/06 | +249 % | 96 10/22 | Stage 2 | B 55 | 7 of 9 | 1.3 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 46.40 $ | +98.0 % | +116.2 % | +227.8 % | −2.4 % | +18.0 % | 92 | 26 | 4.8 % | 5.7 % | 0.86 | — | 52.6 | 14.7 | 42.5 | 82.9 | — | 206.8 | — | 59.7 % | -1.7 % | -5.4 % | 4.8 % | 0.40 | — | +104.9 % | — | 0.0 % | 0.0 % | 0.7 | 65.4 % | 6.3 % | 4.7 (3) |
| UMAC Unusual Machines, Inc. | 08/13 | — | 83 8/25 | Stage 2 | C 52 | 3 of 9 | 1.0 $ | Computer Hardware | Neutral | — | Technology | 21.20 $ | +56.4 % | +30.8 % | +129.0 % | −40.4 % | +64.4 % | 92 | 42 | 10.2 % | 15.0 % | 14.79 | — | 67.6 | 60.9 | 3.0 | — | — | 0.0 | -89.7 % | 35.2 % | -32.7 % | -3.3 % | -10.2 % | 0.00 | 95.8 % | +101.2 % | — | 0.0 % | 0.0 % | 76.3 | 60.2 % | 19.7 % | 4.7 (3) | |
| SEZL Sezzle Inc. | 08/06 | — | 70 6/22 | Stage 2 | A 76 | 6 of 9 | 5.4 $ | Credit Services | Uses AI | — | Financial Services | 154.80 $ | +138.8 % | +131.8 % | -0.1 % | −12.3 % | +5.7 % | 91 | 76 | 8.0 % | 7.4 % | 6.72 | 22.2 | 30.3 | 11.2 | 15.9 | 22.5 | 0.11 | 28.5 | 61.0 % | 74.3 % | 30.8 % | 92.0 % | 47.5 % | 0.74 | 43.3 % | +66.1 % | — | 0.0 % | 0.0 % | 11.4 | 40.9 % | 23.2 % | 5.0 (2) | |
| TGTX TG Therapeutics Inc | 08/03 | +43 % | 53 5/22 | Stage 2 | B 68 | 5 of 9 | 8.0 $ | Biotechnology | Neutral | — | Healthcare | 52.00 $ | +80.9 % | +79.3 % | +46.6 % | −6.5 % | +31.6 % | 90 | 92 | 5.0 % | 4.8 % | 1.60 | 18.9 | 55.2 | 11.5 | 14.2 | — | 1.61 | 54.6 | 17.0 % | 83.1 % | 66.0 % | 112.6 % | 8.6 % | 1.29 | 38.1 % | +87.3 % | — | 0.0 % | 0.0 % | 6.2 | 70.2 % | 29.0 % | 4.3 (9) | |
| ATLC Atlanticus Holdings Corporation | 08/06 | +51 % | 41 4/22 | Stage 2 | B 71 | 6 of 9 | 1.6 $ | Credit Services | Uses AI | — | Financial Services | 105.50 $ | +51.4 % | +49.6 % | +112.6 % | −2.8 % | +19.4 % | 90 | 77 | 6.3 % | 6.0 % | 2.12 | — | 7.9 | 1.3 | — | 2.0 | — | 0.0 | — | 72.4 % | 21.4 % | 21.4 % | 2.5 % | — | — | +53.3 % | — | 0.0 % | 0.0 % | 4.5 | 25.0 % | 25.8 % | 4.3 (7) | |
| ASTH Astrana Health Inc | 08/06 | +13 % | 70 6/22 | Stage 2 | B 62 | 5 of 9 | 1.8 $ | Medical Care Facilities | Uses AI | — | Healthcare | 35.60 $ | +66.1 % | +79.3 % | +49.0 % | −0.5 % | +38.6 % | 89 | 87 | 3.6 % | 3.8 % | 0.89 | — | 23.0 | 0.5 | — | 11.4 | — | 14.4 | 3.0 % | 10.7 % | 0.9 % | 5.7 % | 3.6 % | — | 33.9 % | +56.4 % | — | 0.0 % | 0.0 % | 5.2 | 61.5 % | 10.3 % | 4.5 (12) | |
| NUVB Nuvation Bio Inc | 08/06 | +81 % | 69 6/22 | Stage 2 | B 67 | 6 of 9 | 2.1 $ | Biotechnology | – | — | — | Healthcare | 6.30 $ | -32.6 % | -41.1 % | +168.2 % | −40.4 % | +102.8 % | 89 | 42 | 7.2 % | 7.6 % | 1.53 | — | 0.0 | 14.7 | 7.6 | — | — | 2.2 | 4.7 % | 90.8 % | -102.1 % | -39.5 % | -17.0 % | 0.03 | 52.4 % | +699.0 % | — | 0.0 % | 0.0 % | 2.5 | 64.9 % | 26.5 % | 4.6 (7) |
| NAVN Navan, Inc. Class A Common Stock | — | — | — | Stage 2 | B 59 | 5 of 9 | 0.0 $ | Software - Application | – | — | — | Technology | 26.60 $ | +24.6 % | +49.7 % | — | −11.9 % | +36.2 % | 89 | 50 | 7.0 % | 7.2 % | — | — | 114.9 | — | 4.6 | — | — | 0.0 | — | 72.2 % | -46.7 % | -52.9 % | -8.4 % | 0.14 | — | +30.8 % | — | 0.0 % | 0.0 % | 4.7 | 60.1 % | 19.0 % | — |
| AMPX Amprius Technologies Inc. | 08/06 | +25 % | 90 11/29 | Stage 1 | B 61 | 5 of 9 | 1.4 $ | Electrical Equipment & Parts | Neutral | — | Industrials | 9.60 $ | +79.0 % | +58.5 % | +38.5 % | −48.2 % | +139.6 % | 87 | 42 | 8.7 % | 9.8 % | 2.26 | — | 0.0 | 15.1 | 12.8 | — | — | -34.5 | -23.4 % | 18.1 % | -44.0 % | -44.2 % | -10.6 % | 0.06 | 83.7 % | +202.1 % | — | 0.0 % | 0.0 % | 5.9 | 65.2 % | 20.1 % | 4.4 (7) | |
| ECOR Electrocore LLC | 08/05 | +35 % | 70 6/22 | Stage 2 | C 45 | 4 of 9 | 0.1 $ | Medical Devices | – | — | — | Healthcare | 6.10 $ | +86.2 % | +66.4 % | -12.1 % | −31.5 % | +166.6 % | 87 | 42 | 11.0 % | 11.5 % | 0.89 | — | 384.6 | 1.5 | 29.6 | — | — | 0.2 | — | 87.3 % | -44.1 % | -478.7 % | -58.1 % | -1.67 | — | +27.2 % | — | 0.0 % | 0.0 % | -44.7 | 9.2 % | 2.6 % | — |
| MIRM Mirum Pharmaceuticals Inc | 08/05 | +102 % | 68 6/22 | Stage 2 | C 45 | 3 of 9 | 6.3 $ | Biotechnology | – | — | — | Healthcare | 106.00 $ | +40.6 % | +52.3 % | +105.0 % | −1.9 % | +38.2 % | 86 | 42 | 5.0 % | 5.0 % | 0.49 | — | 39.7 | 11.0 | 28.1 | — | — | 341.2 | -39.5 % | 81.4 % | -140.2 % | -335.8 % | -5.9 % | 1.34 | 27.2 % | +54.7 % | — | 0.0 % | 0.0 % | -5.4 | 114.4 % | 15.6 % | 4.6 (10) |
| FTAI FTAI Aviation Ltd. | 08/04 | +283 % | 76 9/29 | Stage 2 | B 68 | 5 of 9 | 21.0 $ | Aerospace & Defense | – | — | — | Industrials | 206.00 $ | +33.6 % | +52.7 % | +50.9 % | −17.0 % | +82.8 % | 83 | 77 | 6.6 % | 6.4 % | 1.51 | 41.0 | 28.5 | 6.8 | 49.0 | — | 3.22 | 22.2 | 22.5 % | 32.2 % | 15.9 % | 233.3 % | 11.4 % | 10.23 | 9.5 % | +43.2 % | — | 1.0 % | 34.1 % | 8.0 | 97.2 % | 10.6 % | 4.5 (13) |
| DAVE Dave Inc | 08/05 | +2,117 % | 61 6/25 | Stage 2 | A 84 | 6 of 9 | 4.7 $ | Software - Application | Uses AI | — | Technology | 372.70 $ | +43.6 % | +62.5 % | +58.1 % | −5.8 % | +4.5 % | 83 | 86 | 8.5 % | 8.1 % | 3.83 | — | 22.7 | 7.8 | — | 14.4 | — | 22.1 | 38.3 % | 72.1 % | 37.2 % | 111.6 % | 32.0 % | — | 38.4 % | +59.7 % | — | 0.0 % | 0.0 % | 11.6 | 100.1 % | 21.0 % | 4.8 (8) | |
| PSTL Postal Realty Trust Inc | 08/03 | +33 % | 75 6/21 | Stage 2 | B 62 | 6 of 9 | 0.8 $ | REIT - Office | – | — | — | Real Estate | 23.00 $ | +48.7 % | +60.3 % | +75.0 % | −0.6 % | +10.1 % | 82 | 83 | 3.1 % | 2.7 % | 0.79 | 45.2 | 45.2 | 8.0 | 2.2 | 21.6 | — | 17.7 | — | 78.3 % | 15.8 % | 5.9 % | 3.1 % | 1.40 | — | +25.5 % | — | 4.3 % | 1.6 % | 3.6 | 82.9 % | 4.4 % | 4.1 (8) |
| AEVA Aeva Technologies, Inc. | 07/30 | +100 % | 80 8/25 | Stage 2 | C 50 | 5 of 9 | 1.3 $ | Software - Infrastructure | – | — | — | Technology | 17.50 $ | +77.3 % | +90.3 % | -5.9 % | −48.1 % | +43.6 % | 81 | 42 | 12.5 % | 12.1 % | 2.40 | — | 0.0 | 60.6 | 68.6 | — | — | -0.1 | — | 4.6 % | 0.0 % | -516.1 % | -63.2 % | -8.22 | — | +99.4 % | — | 0.0 % | 0.0 % | -16.8 | 66.1 % | 10.2 % | 4.4 (5) |
| WLFC Willis Lease Finance Corporation | 08/04 | +149 % | 59 7/29 | Stage 2 | B 63 | 6 of 9 | 1.7 $ | Rental & Leasing Services | Neutral | — | — | Industrials | 71.30 $ | +55.8 % | +65.6 % | +52.4 % | −7.1 % | +5.7 % | 80 | 77 | 4.7 % | 4.4 % | 0.72 | — | 6.9 | 2.2 | — | — | 0.94 | 9.3 | — | 83.7 % | 16.2 % | 17.6 % | 5.1 % | — | — | +18.7 % | — | 0.8 % | 12.6 % | 5.2 | 47.3 % | 16.1 % | 5.0 (1) |
| PRE Prenetics Global Ltd | — | +16 % | 91 6/16 | Stage 2 | B 60 | 5 of 9 | 0.3 $ | Packaged Foods | Uses AI | — | Consumer Defensive | 18.60 $ | +26.5 % | +9.9 % | +131.0 % | −16.4 % | +57.0 % | 80 | 42 | 6.2 % | 8.5 % | 0.25 | — | 0.0 | 2.8 | 2.6 | — | — | 11.4 | — | 55.4 % | -42.0 % | -40.8 % | -13.5 % | 0.00 | — | +201.7 % | — | 0.0 % | 0.0 % | — | 12.8 % | 4.2 % | — | |
| ARQT Arcutis Biotherapeutics Inc | 08/05 | +66 % | 54 5/22 | Stage 3 | B 65 | 6 of 9 | 3.4 $ | Biotechnology | – | — | — | Healthcare | 26.90 $ | -9.5 % | -9.1 % | +84.2 % | −16.0 % | +28.7 % | 77 | 42 | 4.7 % | 4.6 % | 1.48 | — | 149.3 | 8.2 | 17.9 | 127.3 | — | 226.7 | -8.6 % | 90.9 % | -0.6 % | -1.4 % | 0.5 % | 0.07 | 41.2 % | +91.3 % | — | 0.0 % | 0.0 % | -0.1 | 110.2 % | 11.6 % | 4.6 (7) |
| GKOS Glaukos Corp | 07/29 | +33 % | 68 6/22 | Stage 2 | B 56 | 3 of 9 | 9.7 $ | Medical Devices | – | — | — | Healthcare | 166.70 $ | +19.3 % | +21.9 % | +93.7 % | −3.7 % | +16.1 % | 76 | 98 | 3.9 % | 5.6 % | 0.75 | — | 2,000.0 | 15.9 | 14.6 | — | 1.64 | -57.9 | -13.2 % | 79.1 % | -30.7 % | -26.4 % | -5.2 % | 0.15 | 75.1 % | +32.3 % | — | 0.0 % | 0.0 % | 4.4 | 102.1 % | 9.7 % | 4.3 (15) |
| ABX Abacus Global Management, Inc. | 08/06 | -1 % | 89 8/22 | Stage 2 | B 69 | 8 of 9 | 1.0 $ | Insurance - Life | – | — | — | Financial Services | 10.30 $ | +12.6 % | +26.2 % | +96.4 % | −12.3 % | +36.7 % | 76 | 76 | 4.9 % | 4.7 % | 0.06 | 28.0 | 10.6 | 4.0 | 2.4 | 7.9 | — | 11.5 | — | 88.8 % | 15.6 % | 9.1 % | 7.3 % | 0.81 | — | +110.2 % | — | 1.9 % | 31.8 % | 5.6 | 28.5 % | 20.7 % | — |
| CURB Curbline Properties Corp. | 07/27 | — | 31 3/21 | Stage 2 | B 59 | 4 of 9 | 3.2 $ | REIT - Retail | – | — | — | Real Estate | 30.60 $ | +35.2 % | +36.1 % | +42.5 % | −0.7 % | +8.9 % | 75 | 9 | 2.2 % | 2.3 % | — | — | 50.5 | 15.7 | — | 26.3 | — | 26.5 | 13.1 % | 75.2 % | 13.1 % | 1.7 % | 1.0 % | — | 72.3 % | +51.3 % | — | 2.2 % | 130.2 % | 6.8 | 119.7 % | 29.5 % | 3.4 (9) |
| ALHC Alignment Healthcare LLC | 07/29 | +85 % | 68 6/22 | Stage 3 | B 72 | 7 of 9 | 3.0 $ | Healthcare Plans | Uses AI | — | — | Healthcare | 14.90 $ | +9.7 % | +21.5 % | +7.8 % | −4.9 % | +65.2 % | 72 | 42 | 4.6 % | 5.7 % | 1.05 | 142.3 | 204.1 | 0.7 | 14.2 | 16.1 | — | 31.3 | 1.3 % | 12.6 % | 0.9 % | 12.5 % | 3.1 % | 1.60 | 16.4 % | +46.1 % | — | 0.0 % | 0.0 % | 3.3 | 106.7 % | 12.3 % | 4.1 (11) |
| IDR Idaho Strategic Resources Inc | 08/06 | +168 % | — | Stage 1 | A 77 | 7 of 9 | 0.0 $ | Gold | Neutral | — | Basic Materials | 28.10 $ | -18.9 % | -31.5 % | +71.2 % | −40.5 % | +38.3 % | 72 | 50 | 8.4 % | 8.0 % | 1.21 | 23.3 | 22.0 | — | 4.5 | — | — | 18.9 | — | 69.7 % | 43.3 % | 26.5 % | 15.7 % | 0.02 | — | +64.6 % | — | 0.0 % | 0.0 % | 25.9 | 46.7 % | 8.0 % | — | |
| RYTM Rhythm Pharmaceuticals Inc | 08/04 | +170 % | 39 4/22 | Stage 3 | B 57 | 5 of 9 | 6.7 $ | Biotechnology | – | — | — | Healthcare | 99.30 $ | -0.8 % | -2.0 % | +16.5 % | −11.4 % | +39.8 % | 70 | 42 | 5.8 % | 4.8 % | 1.88 | — | 0.0 | 31.0 | 55.4 | — | — | -12.6 | -87.1 % | 89.4 % | -93.3 % | -101.2 % | -29.8 % | 1.85 | 27.8 % | +45.8 % | — | 0.0 % | 0.0 % | -4.6 | 110.0 % | 14.1 % | 4.7 (12) |
| AMSC American Superconductor Corporation | 07/29 | +203 % | 60 7/29 | Stage 3 | A 79 | 6 of 9 | 1.6 $ | Specialty Industrial Machinery | Neutral | — | — | Industrials | 29.40 $ | +44.6 % | +27.1 % | -48.3 % | −42.9 % | +112.6 % | 66 | 91 | 7.0 % | 7.9 % | 3.22 | — | 28.3 | 5.2 | — | 84.9 | 0.74 | 53.4 | 5.1 % | 30.8 % | 44.7 % | 35.6 % | 2.1 % | — | 75.1 % | +34.3 % | — | 0.0 % | 0.0 % | 4.2 | 69.8 % | 7.3 % | 4.7 (3) |
| XERS Xeris Pharmaceuticals Inc | 08/06 | +49 % | 39 4/22 | Stage 3 | B 73 | 8 of 9 | 1.4 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 8.10 $ | -8.3 % | +7.4 % | +58.7 % | −26.6 % | +39.3 % | 66 | 42 | 3.5 % | 4.0 % | 0.85 | — | 101.0 | 4.4 | — | 29.5 | — | 28.9 | 9.5 % | 85.9 % | 3.8 % | -617.2 % | 6.3 % | — | 3.3 % | +43.7 % | — | 0.0 % | 0.0 % | 0.5 | 62.4 % | 6.0 % | 4.5 (6) |
| NTRA Natera Inc | 08/06 | +119 % | 52 5/22 | Stage 2 | B 57 | 5 of 9 | 38.6 $ | Diagnostics & Research | – | — | — | Healthcare | 267.80 $ | +2.5 % | +15.6 % | +100.3 % | −3.9 % | +5.6 % | 64 | 42 | 6.1 % | 5.4 % | 1.51 | — | 0.0 | 15.4 | 21.6 | 419.2 | — | -26.8 | -12.4 % | 65.1 % | -9.0 % | -15.0 % | -9.1 % | 0.15 | 67.9 % | +35.9 % | — | 0.0 % | 0.0 % | 3.9 | 95.8 % | 3.6 % | 4.5 (21) |
| AFRM Affirm Holdings Inc | 08/27 | +128 % | 53 5/22 | Stage 3 | A 79 | 8 of 9 | 24.1 $ | Credit Services | Uses AI | — | Financial Services | 71.50 $ | -3.5 % | +7.6 % | +4.3 % | −23.2 % | +26.7 % | 63 | 98 | 6.5 % | 6.1 % | 3.67 | 65.7 | 36.4 | 6.1 | 6.4 | 30.6 | 0.72 | 27.4 | 8.5 % | 48.4 % | 9.6 % | 11.5 % | 1.7 % | 2.74 | 28.8 % | +38.8 % | — | 0.0 % | 0.0 % | 9.1 | 86.9 % | 5.7 % | 4.2 (24) | |
| PNTG Pennant Group Inc | 08/05 | +60 % | 88 8/22 | Stage 2 | B 56 | 2 of 9 | 1.4 $ | Medical Care Facilities | – | — | — | Healthcare | 40.30 $ | +21.6 % | +24.3 % | +81.9 % | −4.5 % | +11.7 % | 63 | 58 | 4.2 % | 4.5 % | 1.25 | 46.9 | 30.2 | 1.3 | 4.0 | 29.1 | 2.32 | 28.0 | — | 19.6 % | 3.0 % | 10.0 % | 4.1 % | 1.31 | — | +36.3 % | — | 0.0 % | 0.0 % | 4.7 | 95.1 % | 2.2 % | 3.8 (4) |
| OMDA Omada Health, Inc. Common Stock | 08/06 | — | — | Stage 3 | B 65 | 3 of 9 | 0.0 $ | Health Information Services | – | — | — | Healthcare | 19.80 $ | +16.0 % | +36.1 % | +13.2 % | −29.8 % | +21.3 % | 61 | 50 | 5.3 % | 5.1 % | — | — | 769.2 | — | 4.6 | — | — | 1,364.4 | — | 66.3 % | -2.2 % | -4.3 % | -2.4 % | — | — | +53.2 % | — | 0.0 % | 0.0 % | 6.1 | 81.6 % | 13.4 % | — |
| BROS Dutch Bros Inc | 08/05 | +47 % | 42 6/31 | Stage 2 | B 70 | 4 of 9 | 11.6 $ | Restaurants | – | — | — | Consumer Cyclical | 65.80 $ | +10.2 % | +11.8 % | +11.1 % | −10.8 % | +21.7 % | 56 | 31 | 5.2 % | 5.1 % | 2.32 | 104.0 | 68.5 | 6.6 | 13.1 | 127.8 | 2.36 | 33.8 | 7.7 % | 25.3 % | 4.6 % | 13.8 % | 3.7 % | 1.67 | 22.4 % | +27.9 % | — | 0.0 % | 0.0 % | 4.2 | 98.6 % | 34.7 % | 4.7 (24) |
| RBRK Rubrik, Inc. | — | — | 72 7/25 | Stage 3 | B 65 | 5 of 9 | 14.6 $ | Software - Infrastructure | Sells AI | — | Technology | 72.40 $ | -2.9 % | +12.5 % | -23.8 % | −17.5 % | +31.5 % | 54 | 42 | 5.8 % | 6.2 % | 1.10 | — | 434.8 | 10.2 | 0.0 | 48.4 | — | 0.0 | -13.6 % | 80.6 % | -20.3 % | 0.0 % | -9.0 % | -2.38 | -18.8 % | +48.5 % | — | 0.0 % | 0.0 % | 1.6 | 76.9 % | 8.6 % | 4.9 (29) | |
| HALO Halozyme Therapeutics Inc | 08/04 | +35 % | 88 8/22 | Stage 2 | B 66 | 6 of 9 | 9.7 $ | Biotechnology | – | — | — | Healthcare | 82.50 $ | +3.4 % | +12.8 % | +37.6 % | −11.7 % | +5.3 % | 48 | 71 | 3.6 % | 3.2 % | 0.84 | 29.9 | 11.4 | 6.4 | 46.0 | 14.5 | — | 18.6 | 49.0 % | 76.7 % | 23.1 % | 99.4 % | 22.1 % | 9.77 | 8.2 % | +37.6 % | — | 0.0 % | 0.0 % | 6.5 | 107.2 % | 14.5 % | 3.6 (8) |
| ANIP ANI Pharmaceuticals Inc | 08/14 | +20 % | 80 7/22 | Stage 3 | B 68 | 8 of 9 | 1.8 $ | Drug Manufacturers - Specialty & Generic | – | — | — | Healthcare | 79.20 $ | +5.1 % | +2.4 % | +25.1 % | −16.3 % | +38.9 % | 44 | 84 | 3.1 % | 3.1 % | 0.43 | 20.2 | 8.9 | 2.0 | 3.2 | 11.3 | 1.06 | 9.3 | 16.3 % | 60.8 % | 10.0 % | 18.3 % | 5.0 % | 0.58 | 39.5 % | +43.8 % | — | 0.0 % | 0.0 % | 7.0 | 110.4 % | 18.1 % | 4.3 (6) |
| CBLL CeriBell, Inc | 08/04 | — | — | Stage 1 | C 49 | 2 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 17.70 $ | -16.1 % | -6.8 % | +22.9 % | −18.9 % | +36.1 % | 43 | 50 | 4.9 % | 4.4 % | — | — | 0.0 | — | 5.3 | — | — | 0.0 | — | 87.7 % | -63.5 % | -37.5 % | -20.7 % | 0.16 | — | +36.1 % | — | 0.0 % | 0.0 % | 6.2 | 86.8 % | 8.2 % | — |
| BOW Bowhead Specialty Holdings Inc. | 08/04 | — | — | Stage 2 | B 69 | 6 of 9 | 0.0 $ | Insurance - Property & Casualty | – | — | — | Financial Services | 30.60 $ | -1.1 % | +4.7 % | -5.9 % | −25.6 % | +11.2 % | 42 | 50 | 3.9 % | 4.0 % | -0.11 | 16.0 | 14.9 | — | 2.0 | — | — | 0.0 | — | 32.1 % | 10.0 % | 13.7 % | 2.5 % | 0.32 | — | +29.6 % | — | 0.0 % | 0.0 % | 8.3 | 93.9 % | 4.3 % | — |
| KMTS Kestra Medical Technologies, Ltd. | — | — | 56 5/22 | Stage 4 | B 56 | 5 of 9 | 1.3 $ | Medical Instruments & Supplies | – | — | — | Healthcare | 22.80 $ | -22.0 % | -7.9 % | +38.4 % | −24.7 % | +31.6 % | 36 | 42 | 8.1 % | 7.3 % | — | — | 0.0 | 13.4 | 4.6 | — | — | 0.0 | — | 51.4 % | -138.4 % | -92.7 % | -25.8 % | 0.02 | — | +115.1 % | — | 0.0 % | 0.0 % | 3.6 | 102.9 % | 10.0 % | 4.5 (6) |
| SKYH Sky Harbour Group Corporation | 08/11 | +34 % | 31 3/21 | Stage 3 | B 65 | 5 of 9 | 0.8 $ | Real Estate - Development | – | — | — | Real Estate | 10.70 $ | +6.1 % | +6.3 % | +9.5 % | −17.4 % | +52.6 % | 33 | 90 | 3.2 % | 3.9 % | 1.31 | — | 12.4 | 26.7 | — | — | — | 54.8 | — | -46.6 % | 63.9 % | 4.7 % | -2.7 % | — | — | +86.6 % | — | 0.0 % | 0.0 % | 3.3 | 38.4 % | 13.4 % | 4.5 (6) |
| SLDE Slide Insurance Holdings, Inc. Common Stock | 08/11 | — | — | Stage 1 | B 62 | 7 of 9 | 0.0 $ | Insurance - Property & Casualty | – | — | — | Financial Services | 20.00 $ | -10.3 % | +1.0 % | +6.2 % | −20.2 % | +39.5 % | 32 | 50 | 4.5 % | 3.7 % | — | — | 0.0 | — | — | — | — | 0.0 | 47.9 % | 66.9 % | 38.9 % | 59.7 % | 17.0 % | — | 38.6 % | +36.5 % | — | 0.0 % | 0.0 % | 7.3 | 47.7 % | 8.5 % | — |
| RDDT Reddit, Inc. | 07/30 | — | 83 8/24 | Stage 4 | A 89 | 8 of 9 | 28.6 $ | Internet Content & Information | Sells AI | — | — | Communication Services | 140.70 $ | -27.9 % | -22.8 % | -12.4 % | −44.2 % | +55.1 % | 31 | 96 | 6.8 % | 6.8 % | 1.94 | 40.3 | 31.0 | 10.3 | 8.5 | 28.1 | 1.01 | 30.3 | 27.6 % | 91.4 % | 31.4 % | 26.2 % | 15.7 % | 0.01 | 91.3 % | +69.4 % | — | 0.0 % | 0.0 % | 21.0 | 93.6 % | 12.1 % | 3.9 (26) |
| VEL Velocity Financial Llc | 08/06 | +14 % | 40 4/22 | Stage 4 | B 66 | 4 of 9 | 0.7 $ | Mortgage Finance | – | — | — | Financial Services | 17.50 $ | -14.9 % | -7.9 % | +5.7 % | −17.0 % | +24.8 % | 30 | 59 | 2.5 % | 2.6 % | 0.70 | 6.4 | 0.0 | 1.0 | 1.0 | 25.6 | — | 0.0 | — | 74.9 % | 40.0 % | 17.2 % | 1.6 % | 9.70 | — | +48.0 % | — | 0.0 % | 0.0 % | 3.7 | 98.9 % | 29.7 % | 3.3 (3) |
| S SentinelOne Inc | 08/27 | -1 % | 73 7/25 | Stage 3 | B 58 | 5 of 9 | 6.4 $ | Software - Infrastructure | – | — | — | Technology | 19.10 $ | +0.9 % | +12.7 % | +3.9 % | −30.1 % | +3.0 % | 29 | 42 | 4.8 % | 5.3 % | 0.83 | — | 56.2 | 6.1 | 4.6 | 143.6 | — | -11.0 | -28.8 % | 73.3 % | -30.4 % | -21.4 % | -7.9 % | — | 61.0 % | +21.9 % | — | 0.0 % | 0.0 % | 1.9 | 84.6 % | 6.4 % | 4.4 (36) |
| PHAT Phathom Pharmaceuticals Inc | 08/06 | -19 % | 81 7/22 | Stage 4 | B 70 | 5 of 9 | 0.7 $ | Biotechnology | – | — | — | Healthcare | 8.80 $ | -34.5 % | -38.4 % | +2.5 % | −43.5 % | +148.9 % | 28 | 42 | 5.8 % | 6.2 % | 0.49 | — | 0.0 | 2.9 | 21.6 | — | — | -2.2 | — | 82.9 % | -41.3 % | -3,489.0 % | -8.8 % | -0.49 | — | +216.9 % | — | 0.0 % | 0.0 % | -12.2 | 89.2 % | 16.0 % | 4.6 (9) |
| LMND Lemonade Inc | 08/04 | +81 % | 39 4/22 | Stage 4 | B 64 | 4 of 9 | 3.7 $ | Insurance - Property & Casualty | – | — | — | Financial Services | 48.30 $ | -18.7 % | -22.1 % | +28.2 % | −44.0 % | +26.8 % | 27 | 42 | 6.2 % | 6.3 % | 1.79 | — | 0.0 | 4.5 | — | 189.2 | — | 0.0 | -11.0 % | 51.7 % | -14.2 % | -26.1 % | -3.5 % | — | 26.5 % | +40.2 % | — | 0.0 % | 0.0 % | 0.9 | 59.7 % | 14.5 % | 2.4 (9) |
| SUNS Sunrise Realty Trust, Inc. | 08/06 | — | — | Stage 4 | B 58 | 4 of 9 | 0.0 $ | REIT - Mortgage | – | — | — | Real Estate | 7.80 $ | -7.0 % | -8.5 % | -10.5 % | −27.1 % | +29.5 % | 27 | 50 | 3.4 % | 3.3 % | — | — | 7.1 | — | — | — | 0.65 | 18.5 | — | 100.0 % | 59.7 % | 7.2 % | 4.7 % | — | — | +148.1 % | — | 14.7 % | 117.7 % | 8.0 | 33.9 % | 7.2 % | — |
| CARL Carlsmed, Inc. Common Stock | — | — | 41 4/22 | Stage 4 | C 51 | 5 of 9 | 0.4 $ | Health Information Services | – | — | — | Healthcare | 12.60 $ | -13.4 % | -19.5 % | -10.5 % | −34.6 % | +47.6 % | 26 | 42 | 7.7 % | 7.2 % | — | — | 0.0 | 6.5 | 3.7 | — | — | 0.0 | — | 75.9 % | -57.8 % | -52.4 % | -24.2 % | 0.19 | — | +85.9 % | — | 0.0 % | 0.0 % | 8.1 | 39.7 % | 13.4 % | — |
| PLMR Palomar Holdings Inc | 08/03 | +31 % | 88 8/22 | Stage 4 | B 66 | 6 of 9 | 3.6 $ | Insurance - Property & Casualty | – | — | — | Financial Services | 133.80 $ | -13.9 % | -7.1 % | +1.0 % | −27.0 % | +22.6 % | 24 | 42 | 3.9 % | 3.9 % | 0.41 | 20.0 | 0.0 | 3.6 | 4.0 | 9.8 | — | 0.0 | 20.3 % | 28.7 % | 20.1 % | 22.5 % | 5.3 % | 0.31 | 26.6 % | +58.2 % | — | 0.0 % | 0.0 % | 6.5 | 100.6 % | 5.1 % | 4.1 (8) |
| LPLA LPL Financial Holdings Inc | 07/30 | +15 % | 88 8/22 | Stage 4 | B 61 | 4 of 9 | 28.5 $ | Capital Markets | – | — | — | Financial Services | 353.70 $ | -17.2 % | -27.7 % | -10.3 % | −31.3 % | +21.1 % | 22 | 54 | 3.6 % | 3.9 % | 0.51 | 30.9 | 14.2 | 1.6 | 4.8 | — | 0.53 | 13.9 | 11.1 % | 29.9 % | 5.2 % | 20.5 % | 5.4 % | 2.61 | 30.2 % | +37.2 % | — | 0.3 % | 5.5 % | 7.3 | 105.8 % | 6.1 % | 4.2 (15) |
| BULL Webull Corp | 08/13 | -29 % | — | Stage 4 | C 46 | 1 of 9 | 0.0 $ | Software - Application | – | — | — | Technology | 7.10 $ | -14.5 % | -19.5 % | -50.3 % | −64.5 % | +84.3 % | 22 | 50 | 6.4 % | 6.7 % | 0.55 | — | 37.7 | — | 3.2 | — | — | 109.9 | -1.5 % | 76.3 % | -1.7 % | -1.3 % | -0.4 % | 0.08 | 27.4 % | +46.3 % | — | 0.0 % | 0.0 % | 3.4 | 51.2 % | 4.9 % | — |
| GRND Grindr Inc | 08/06 | +45 % | 87 9/25 | Stage 3 | A 75 | 7 of 9 | 3.1 $ | Software - Application | Uses AI | — | — | Technology | 17.30 $ | -3.0 % | +5.9 % | -0.8 % | −41.0 % | +8.7 % | 22 | 80 | 5.4 % | 4.8 % | 0.22 | 39.8 | 0.0 | 6.5 | 3,875.5 | 21.2 | — | 23.1 | — | 74.7 % | 19.9 % | 58.9 % | 16.3 % | 23.84 | — | +27.6 % | — | 0.0 % | 0.0 % | 5.0 | 21.4 % | 18.2 % | 4.3 (4) |
| GTLB Gitlab Inc | 09/02 | -15 % | 46 5/25 | Stage 4 | B 59 | 6 of 9 | 5.7 $ | Software - Infrastructure | – | — | — | Technology | 34.50 $ | -28.1 % | -20.4 % | -21.2 % | −47.5 % | -1.1 % | 20 | 42 | 5.4 % | 6.2 % | 0.96 | — | 42.0 | 5.7 | 6.1 | 21.8 | — | -32.5 | -6.0 % | 86.8 % | -2.5 % | -3.0 % | -2.0 % | — | 57.8 % | +25.8 % | — | 0.0 % | 0.0 % | 6.2 | 86.3 % | 11.5 % | 4.5 (28) |
| BBNX Beta Bionics, Inc. Common Stock | 08/04 | — | — | Stage 4 | D 44 | 3 of 9 | 0.0 $ | Medical Devices | – | — | — | Healthcare | 12.80 $ | -55.1 % | -45.3 % | -23.6 % | −51.4 % | +20.6 % | 20 | 50 | 7.8 % | 7.6 % | — | — | 0.0 | — | 2.1 | — | — | 0.0 | — | 57.2 % | -60.3 % | -22.7 % | -15.0 % | 0.03 | — | +53.9 % | — | 0.0 % | 0.0 % | 11.0 | 112.6 % | 10.5 % | — |
| IOT Samsara Inc | 09/03 | +7 % | 45 5/25 | Stage 4 | A 75 | 8 of 9 | 21.6 $ | Software - Infrastructure | Sells AI | — | Technology | 37.30 $ | -11.7 % | -12.2 % | -2.0 % | −39.0 % | +18.8 % | 19 | 42 | 5.7 % | 6.6 % | 1.35 | 400.8 | 52.4 | 12.5 | 15.5 | 92.1 | — | 1,426.6 | 1.5 % | 76.3 % | 3.3 % | 4.4 % | -0.3 % | 0.05 | 57.7 % | +29.6 % | — | 0.0 % | 0.0 % | 4.3 | 102.6 % | 12.6 % | 4.0 (21) | |
| EVLV Evolv Technologies Holdings Inc | 08/13 | -2 % | 85 10/29 | Stage 4 | C 47 | 3 of 9 | 1.0 $ | Security & Protection Services | – | — | — | Industrials | 5.50 $ | -22.6 % | -15.8 % | -15.6 % | −41.3 % | +84.1 % | 19 | 42 | 4.8 % | 4.8 % | 1.77 | — | 43.3 | 6.2 | 8.6 | — | — | -5.1 | — | 49.8 % | -22.8 % | -30.2 % | -5.8 % | 0.35 | — | +40.5 % | — | 0.0 % | 0.0 % | -0.5 | 72.9 % | 5.2 % | 4.5 (4) |
| LIF Life360, Inc. Common Stock | 08/10 | — | 61 6/25 | Stage 4 | B 71 | 4 of 9 | 4.5 $ | Software - Application | – | — | — | Technology | 54.10 $ | -26.8 % | -13.5 % | -29.4 % | −56.5 % | +18.7 % | 18 | 17 | 7.1 % | 5.9 % | 1.11 | 33.5 | 84.7 | 8.5 | 7.9 | 52.1 | — | 169.6 | — | 77.1 % | 28.2 % | 30.7 % | 0.7 % | 0.52 | — | +31.8 % | — | 0.0 % | 0.0 % | 7.4 | 53.3 % | 13.0 % | 4.9 (7) |
| DOMH Dominari Holdings Inc. | 08/10 | -21 % | 57 5/22 | Stage 4 | D 34 | 5 of 9 | 0.1 $ | Capital Markets | – | — | — | Financial Services | 2.50 $ | -26.9 % | -17.3 % | -30.8 % | −66.4 % | +467.4 % | 18 | 42 | 8.1 % | 7.8 % | 0.83 | — | 0.0 | 0.4 | 1.9 | — | — | 1.7 | — | 100.0 % | -31.2 % | -122.5 % | -65.8 % | 0.09 | — | +578.4 % | — | 4.2 % | 0.0 % | -2.2 | 8.8 % | 4.2 % | — |
| GNSS Genasys Inc | 08/13 | -13 % | 62 6/25 | Stage 4 | B 62 | 6 of 9 | 0.1 $ | Scientific & Technical Instruments | – | — | — | Technology | 1.70 $ | -23.1 % | -20.3 % | +3.7 % | −39.3 % | +194.7 % | 18 | 3 | 5.6 % | 5.5 % | 0.73 | — | 12.7 | 1.2 | 26.3 | — | — | 128.6 | — | 45.9 % | -13.4 % | -144.2 % | -6.3 % | 5.74 | — | +69.8 % | — | 0.0 % | 0.0 % | -5.6 | 58.0 % | 2.0 % | — |
| DUOL Duolingo Inc | 08/05 | -2 % | 79 8/25 | Stage 3 | A 77 | 4 of 9 | 6.0 $ | Software - Application | Sells AI | — | Technology | 134.80 $ | -24.7 % | -35.8 % | -61.1 % | −74.4 % | -14.8 % | 16 | 68 | 6.5 % | 6.5 % | 0.88 | 16.1 | 20.0 | 5.5 | 5.0 | 14.5 | — | 29.9 | 15.4 % | 72.7 % | 38.4 % | 37.0 % | 5.9 % | 0.07 | 67.6 % | +38.7 % | — | 0.0 % | 0.0 % | 9.6 | 98.5 % | 21.4 % | 3.9 (23) | |
| GENI Genius Sports Ltd | 08/05 | 0 % | 50 5/24 | Stage 4 | C 46 | 1 of 9 | 1.9 $ | Internet Content & Information | – | — | — | Communication Services | 6.90 $ | -46.8 % | -41.1 % | -38.4 % | −60.4 % | +47.8 % | 16 | 42 | 7.2 % | 7.8 % | 1.90 | — | 56.8 | 2.6 | 2.8 | 1,440.8 | — | 152.7 | -15.8 % | 22.7 % | -22.3 % | -22.6 % | -10.1 % | 0.04 | 68.3 % | +31.0 % | — | 0.0 % | 0.0 % | 1.3 | 90.7 % | 13.5 % | 4.7 (15) |
| ASST Strive Asset Management | 08/04 | -33 % | 55 5/22 | Stage 4 | D 40 | 3 of 9 | 1.0 $ | Asset Management | – | — | — | Financial Services | 11.10 $ | -5.5 % | -32.6 % | -83.3 % | −42.3 % | +161.3 % | 12 | 42 | 9.8 % | 9.0 % | 13.21 | — | 0.9 | 131.9 | 1.3 | — | — | -2.3 | — | -535.7 % | 0.0 % | -125.4 % | -62.6 % | 0.01 | — | +57.1 % | — | 0.0 % | 0.0 % | 44.2 | 47.7 % | 30.4 % | — |
| GEVO Gevo Inc | 08/10 | +2 % | 76 7/23 | Stage 4 | B 58 | 4 of 9 | 0.4 $ | Specialty Chemicals | – | — | — | Basic Materials | 1.50 $ | -30.0 % | -31.9 % | +13.9 % | −52.9 % | +259.2 % | 11 | 42 | 6.7 % | 5.6 % | 1.02 | — | 0.0 | 2.2 | — | — | — | 28.9 | — | 45.8 % | -19.4 % | -6.9 % | -0.8 % | — | — | +849.3 % | — | 0.0 % | 0.0 % | 2.1 | 37.2 % | 11.4 % | 3.3 (3) |
| AXON Axon Enterprise Inc. | 08/03 | +43 % | 66 8/29 | Stage 4 | B 56 | 5 of 9 | 42.8 $ | Aerospace & Defense | – | — | — | Industrials | 527.80 $ | -23.8 % | -13.6 % | -30.1 % | −49.8 % | +25.2 % | 10 | 84 | 6.8 % | 6.5 % | 1.38 | 217.8 | 66.7 | 14.4 | 12.0 | 2,197.0 | 4.17 | 136.4 | 3.8 % | 59.5 % | 6.9 % | 6.8 % | 0.1 % | 1.12 | 50.0 % | +33.5 % | — | 0.0 % | 0.0 % | 6.5 | 88.7 % | 5.5 % | 4.2 (17) |
| RBLX Roblox Corp | 07/30 | +8 % | 83 8/24 | Stage 4 | B 59 | 6 of 9 | 25.6 $ | Electronic Gaming & Multimedia | – | — | — | Communication Services | 35.60 $ | -41.9 % | -33.6 % | -74.2 % | −69.2 % | +57.5 % | 6 | 42 | 8.4 % | 6.6 % | 1.41 | — | 192.3 | 4.5 | 61.0 | 14.5 | 8.18 | -24.8 | -16.4 % | 25.7 % | -17.6 % | -311.9 % | -7.7 % | 2.16 | 4.4 % | +35.8 % | — | 0.0 % | 0.0 % | 0.4 | 83.0 % | 4.5 % | 4.1 (35) |
| ZS Zscaler Inc | 09/02 | -4 % | 72 7/25 | Stage 4 | C 50 | 3 of 9 | 24.4 $ | Software - Infrastructure | – | — | — | Technology | 151.20 $ | -43.9 % | -40.1 % | -47.1 % | −63.3 % | +27.4 % | 6 | 42 | 5.0 % | 7.0 % | 0.96 | — | 32.9 | 7.7 | 11.0 | 25.5 | 1.65 | 158.1 | -3.3 % | 76.7 % | -2.4 % | -3.7 % | -1.4 % | 0.79 | 33.3 % | +23.3 % | — | 0.0 % | 0.0 % | 5.2 | 58.0 % | 7.7 % | 4.2 (46) |
| TMDX TransMedics Group Inc | 07/29 | -3 % | 81 7/22 | Stage 4 | B 66 | 5 of 9 | 2.6 $ | Medical Devices | – | — | — | Healthcare | 76.50 $ | -39.3 % | -47.0 % | -35.7 % | −50.2 % | +43.3 % | 6 | 8 | 6.6 % | 6.1 % | 1.88 | 15.4 | 41.0 | 4.2 | 4.7 | 17.5 | — | 21.8 | 7.6 % | 59.1 % | 27.0 % | 45.2 % | 5.2 % | 1.75 | 34.4 % | +37.1 % | — | 0.0 % | 0.0 % | 6.1 | 108.9 % | 34.8 % | 4.2 (9) |
| GWRE Guidewire Software Inc | 09/03 | +19 % | 72 7/25 | Stage 4 | B 58 | 3 of 9 | 11.8 $ | Software - Application | – | — | — | Technology | 151.90 $ | -45.5 % | -41.3 % | -32.8 % | −59.6 % | +30.6 % | 5 | 10 | 5.9 % | 6.5 % | 0.95 | 90.1 | 36.4 | 8.3 | 10.6 | 46.5 | 0.83 | 63.1 | 8.2 % | 64.0 % | 11.3 % | 11.9 % | 2.9 % | 0.79 | 52.0 % | +22.6 % | — | 0.0 % | 0.0 % | 5.6 | 104.8 % | 6.9 % | 3.9 (16) |
| BTCS BTCS Inc | 08/12 | -20 % | 41 4/22 | Stage 4 | E 23 | 3 of 9 | 0.1 $ | Capital Markets | – | — | — | Financial Services | 1.00 $ | -59.5 % | -64.1 % | -77.2 % | −88.1 % | +395.0 % | 3 | 9 | 10.1 % | 8.6 % | 3.39 | — | 55.9 | 3.3 | 0.7 | — | — | 0.0 | — | 17.1 % | 0.0 % | -184.0 % | -5.7 % | 0.78 | — | +304.9 % | — | 4.5 % | 3.1 % | -1.6 | 22.0 % | 6.5 % | — |
| LCID Lucid Group Inc | 08/04 | -30 % | 33 5/31 | Stage 4 | D 44 | 1 of 9 | 2.9 $ | Auto Manufacturers | – | — | — | Consumer Cyclical | 7.40 $ | -50.9 % | -44.9 % | -70.0 % | −79.7 % | +12.2 % | 2 | 42 | 8.0 % | 7.4 % | 0.83 | — | 0.0 | 2.1 | 4.6 | — | — | -2.1 | — | -95.6 % | -239.8 % | -97.6 % | -28.2 % | 1.55 | — | +67.6 % | — | 0.0 % | 0.0 % | -6.5 | 61.9 % | 40.3 % | 2.9 (15) |
| FEMY Femasys Inc | 08/14 | -33 % | 57 5/22 | Stage 4 | B 60 | 7 of 9 | 0.0 $ | Medical Instruments & Supplies | – | — | — | Healthcare | 2.90 $ | -65.2 % | -74.3 % | -82.8 % | −42.7 % | +1,659.3 % | 2 | 42 | 9.7 % | 11.2 % | -2.13 | — | 0.0 | 3.5 | 1.2 | — | — | 0.2 | — | 61.6 % | 0.0 % | -256.0 % | -68.7 % | 0.65 | — | +40.8 % | — | 0.0 % | 0.0 % | -25.1 | 10.1 % | 6.9 % | — |
| CSAI Cloudastructure, Inc. Class A Common Stock | — | — | 35 4/25 | Stage 4 | C 45 | 5 of 9 | 0.2 $ | Software - Infrastructure | – | — | — | Technology | 5.80 $ | -63.9 % | -69.6 % | -89.9 % | −88.7 % | +1,328.6 % | 1 | 42 | 19.8 % | 14.8 % | — | — | 0.0 | 36.3 | — | — | — | 0.0 | — | 29.4 % | -167.0 % | -201.3 % | -94.9 % | — | — | +271.4 % | — | 0.0 % | 0.0 % | -5.5 | 6.0 % | 2.1 % | — |
| NBIS Nebius Group N.V. | — | — | — | — | B 59 | — | 42.0 $ | Internet Content & Information | – | — | Communication Services | 190.40 $ | — | — | +249.8 % | — | +35.6 % | — | — | — | — | 1.40 | — | 68.5 | 47.8 | 7.4 | — | 0.63 | 32.1 | — | 72.1 % | 93.1 % | — | -3.0 % | — | — | — | — | 0.0 % | 0.0 % | — | — | 28.0 % | 4.7 (3) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
Consistently high revenue growth: in each of the last 6 quarters, revenue was at least 20% above the same quarter a year earlier (year-over-year). This filters out stocks that only grew strongly in a single quarter — the goal is steady, fast growth sustained over a year and a half. Requirement: at least 6 quarters of data history.
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 83 stocks pass this scanner's criteria (as of 3. August 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- Ben Bennett: Focus List
- Ben Bennett: Power Screen
- Dan Zanger: Leader
- EPS & Revenue Power
- EPS Acceleration
- Jim Roppel: 20/20 Screen
- Joshua
- Martin Zweig: Growth with Reason
- Matt Caruso: Sales Leader
- Patrick Walker: 30% EPS Growth
- Patrick Walker: 40, 40 Screen
- Quality Growth
- Small Caps with Growth
- Ted Zhang: Super Stock Universe
- Thomas' Favorites
- Triple-Digit Revenue Growth
- William O'Neil (CAN SLIM)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.